1. Home
  2. PRTC vs GCMG Comparison

PRTC vs GCMG Comparison

Compare PRTC & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • GCMG
  • Stock Information
  • Founded
  • PRTC 2015
  • GCMG 1971
  • Country
  • PRTC United States
  • GCMG United States
  • Employees
  • PRTC N/A
  • GCMG N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • GCMG Finance/Investors Services
  • Sector
  • PRTC Health Care
  • GCMG Finance
  • Exchange
  • PRTC Nasdaq
  • GCMG Nasdaq
  • Market Cap
  • PRTC 509.0M
  • GCMG 524.4M
  • IPO Year
  • PRTC N/A
  • GCMG N/A
  • Fundamental
  • Price
  • PRTC $22.55
  • GCMG $12.33
  • Analyst Decision
  • PRTC Buy
  • GCMG Hold
  • Analyst Count
  • PRTC 1
  • GCMG 5
  • Target Price
  • PRTC $45.00
  • GCMG $12.80
  • AVG Volume (30 Days)
  • PRTC 4.5K
  • GCMG 297.6K
  • Earning Date
  • PRTC 08-28-2024
  • GCMG 11-08-2024
  • Dividend Yield
  • PRTC N/A
  • GCMG 3.57%
  • EPS Growth
  • PRTC N/A
  • GCMG N/A
  • EPS
  • PRTC N/A
  • GCMG N/A
  • Revenue
  • PRTC $468,000.00
  • GCMG $462,593,000.00
  • Revenue This Year
  • PRTC N/A
  • GCMG $15.24
  • Revenue Next Year
  • PRTC $139.60
  • GCMG $13.65
  • P/E Ratio
  • PRTC N/A
  • GCMG $162.65
  • Revenue Growth
  • PRTC N/A
  • GCMG 8.20
  • 52 Week Low
  • PRTC $17.08
  • GCMG $8.04
  • 52 Week High
  • PRTC $34.00
  • GCMG $12.58
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 59.26
  • GCMG 61.96
  • Support Level
  • PRTC $20.61
  • GCMG $11.40
  • Resistance Level
  • PRTC $22.83
  • GCMG $12.58
  • Average True Range (ATR)
  • PRTC 0.69
  • GCMG 0.40
  • MACD
  • PRTC 0.04
  • GCMG 0.05
  • Stochastic Oscillator
  • PRTC 68.44
  • GCMG 85.03

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: